Institute: University of Oxford
Dr Gibani studied medicine at the University of Oxford and graduated in 2010. After continuing his training in general medicine he joined the Oxford Vaccine Group in 2014 working on a range of vaccine trials for Ebola virus disease, meningococcal disease and enteric fever. He is currently undertaking a DPhil focussing on the use of Salmonella controlled human infection models to better understand infection-derived immunity to Salmonella Typhi and Paratyphi infection, as well as studying the role of typhoid toxin in the pathogenesis of typhoid fever.
A list of key publications can be found here.
Web Links of Interest